Melek Aslan Kayıran, Ayşe Serap Karadağ, İlteriş Oğuz Topal, et al.
Issues - Ottobre 2022
Melek Aslan Kayıran, Ayşe Serap Karadağ, İlteriş Oğuz Topal, et al.
Alessandra Narcisi, Mario Valenti, Luigi Gargiulo, et al.
Real-life effectiveness of tildrakizumab in chronic plaque psoriasis: a 52-week multicenter retrospective study – IL PSO (ITALIAN LANDSCAPE PSORIASIS)
J Eur Acad Dermatol Venereol. 2022 Sep 26. Online ahead of printNeuza da Silva, Matthias Augustin, Caroline Hilbring, et al.
Psychological (co)morbidity in patients with psoriasis: the impact of pruritus and anogenital involvement on symptoms of depression and anxiety and on body dysmorphic concerns – a cross-sectional study
BMJ Open. 2022 Sep 23;12(9):e055477Marta Olejárová, Želmíra Macejová, Spyridon Gkalpakiotis, et al.
Reproductive healthcare in women with rheumatoid arthritis and psoriatic diseases in routine clinical practice: survey results of rheumatologists and dermatologists
Rheumatol Ther. 2022 Sep 24. Online ahead of printAkimichi Morita, Yukie Yamaguchi, Chiharu Tateishi, et al.
Efficacy and safety of apremilast and phototherapy versus phototherapy only in psoriasis vulgaris
J Dermatol. 2022 Sep 24. Online ahead of printKacper Nijakowski, Dawid Gruszczyński, Julia Kolasińska, et al.
Periodontal disease in patients with psoriasis: a systematic review
Int J Environ Res Public Health. 2022 Sep 8;19(18):11302Joel M Gelfand, Daniel B Shin, April W Armstrong, et al.
Association of apremilast with vascular inflammation and cardiometabolic function in patients with psoriasis: the VIP-A Phase 4, open-label, nonrandomized clinical trial
JAMA Dermatol. 2022 Sep 21. Online ahead of printMark G Lebwohl, Leon H Kircik, Angela Y Moore, et al.
Effect of roflumilast cream vs vehicle cream on chronic plaque psoriasis: the DERMIS-1 and DERMIS-2 randomized clinical trials
JAMA. 2022 Sep 20;328(11):1073-1084Ranju Pokharel, Sudha Agrawal, Prajwal Pandey, et al.